Cargando…
Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is currently the most prevalent cause of chronic liver disease (CLD). Currently, the only therapeutic recommendation available is a lifestyle change. However, adherence to this approach is often difficult to guarantee. Alteration of the microbiota and an inc...
Autores principales: | Del Barrio, María, Lavín, Lucía, Santos-Laso, Álvaro, Arias-Loste, Maria Teresa, Odriozola, Aitor, Rodriguez-Duque, Juan Carlos, Rivas, Coral, Iruzubieta, Paula, Crespo, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094628/ https://www.ncbi.nlm.nih.gov/pubmed/37047094 http://dx.doi.org/10.3390/ijms24076123 |
Ejemplares similares
-
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review
por: Odriozola, Aitor, et al.
Publicado: (2023) -
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key
por: Alonso-Peña, Marta, et al.
Publicado: (2023) -
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets
por: Santos-Laso, Alvaro, et al.
Publicado: (2021) -
Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)
por: Lavín-Alconero, Lucía, et al.
Publicado: (2021) -
Paving the way to metastasis
por: Van Epps, Heather L.
Publicado: (2005)